Comparative evaluation of potential drug interactions in patients
followed in the internal medicine intensive care unit using different
databases and evaluation of the factors affecting this
- Ahmet Özyürek,
- Murat Aysin,
- İsmail Yılmaz,
- Ali Yıldırım
İsmail Yılmaz
Ministry of Health İzmir Katip Çelebi University Atatürk Education and Research Hospital
Author ProfileAli Yıldırım
Ministry of Health İzmir Katip Çelebi University Atatürk Education and Research Hospital
Author ProfileAbstract
not-yet-known
not-yet-known
not-yet-known
unknown
Aim: Drug interactions are a significant healthcare concern frequently
encountered in intensive care units. Our study aims to acquire more
up-to-date data and raise awareness of drug interactions. Methods: A
retrospective analysis was performed on the data of 163 patients
admitted to the intensive care unit in 2019. The patients’ medication
lists were evaluated on a daily basis, and drug information was analyzed
using three different online databases: Micromedex, Lexicomp, and
Drugs.com. Results: The length of hospital stay ranged from 1 to 50
days, and a total of 1,834 medication orders were analyzed. The most
common admission diagnoses were pneumonia, acute renal failure, and
gastrointestinal bleeding. Comorbidities were present in 81.6% of
patients. The number of interactions increased significantly with
increasing comorbidities and number of drugs. This association was
particularly evident for cardiovascular diseases. The number of
interactions was higher in men. Interactions were identified in 82.9%
of orders in Micromedex, 92.5% in Lexicomp, and 95.5% in Drugs.com.
The most common contraindicated interaction was between linezolid and
tramadol, while the most common major interaction was between aspirin
and enoxaparin. Linezolid, fluconazole, and metoclopramide were the most
common drugs contributing to contraindicated interactions, while
enoxaparin, aspirin, and clopidogrel were the main contributors to major
interactions. Albuterol, norepinephrine, and pantoprazole were
associated with more moderate interactions. Conclusion: Assessment of
drug interactions can lead to improved patient outcomes and avoidance of
unnecessary economic burden. Clinicians should use several sources when
performing such assessments. There are significant differences between
databases.